Comparing a fecal immunochemical test and circulating tumor DNA blood test for colorectal cancer screening adherence.

Geraldine Laven-Law Erin Leigh Symonds Jean M Winter Gang Chen Ingrid Helen K Flight Donna Hughes-Barton Carlene J Wilson Graeme Paul Young

Published in: Journal of gastroenterology and hepatology (2024)

Targeted interventions to improve CRC screening awareness and increase patient health activation may improve CRC screening adherence. A ctDNA blood test may be a suitable CRC screening option to maintain CRC screening adherence in people who do not participate in screening with FIT.

Keyphrases

circulating tumor
colorectal cancer screening
cell free
public health
mental health
circulating tumor cells
risk assessment
case report
single molecule
health information
social media